Healthier Hearts and Brains in Treating Smoking: The HABITS Study
| Status: | Completed |
|---|---|
| Conditions: | Smoking Cessation |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 4/2/2016 |
| Start Date: | November 2009 |
| End Date: | June 2011 |
| Contact: | Hilary Tindle, MD |
| Email: | tindleha@upmc.edu |
| Phone: | 412 246 6929 |
80 nicotine dependent adults ages 18-65 who desire to quit smoking will be screened and, if
eligible, enrolled and randomized to one of two four-week treatments for smoking cessation.
The treatments are standard behavioral therapy and Mindfulness Based Addiction Therapy
(MBAT), which is standard therapy plus mindfulness. Standard therapy and MBAT incorporate
elements of widely-used tools for smoking cessation including managing craving and strong
emotions, problem solving, tips on healthy eating and keeping active, and exercises based on
cognitive and behavioral therapy. MBAT uniquely incorporates mindfulness practice (a
relaxation therapy) into standard therapy. Participants complete questionnaires and undergo
an fMRI scan at baseline and at the end of therapy (after they complete the 4 weeks of
standard therapy or MBAT). During each scan, participants will complete a validated
smoking-related cue paradigm and a validated affect labeling paradigm.
eligible, enrolled and randomized to one of two four-week treatments for smoking cessation.
The treatments are standard behavioral therapy and Mindfulness Based Addiction Therapy
(MBAT), which is standard therapy plus mindfulness. Standard therapy and MBAT incorporate
elements of widely-used tools for smoking cessation including managing craving and strong
emotions, problem solving, tips on healthy eating and keeping active, and exercises based on
cognitive and behavioral therapy. MBAT uniquely incorporates mindfulness practice (a
relaxation therapy) into standard therapy. Participants complete questionnaires and undergo
an fMRI scan at baseline and at the end of therapy (after they complete the 4 weeks of
standard therapy or MBAT). During each scan, participants will complete a validated
smoking-related cue paradigm and a validated affect labeling paradigm.
Inclusion Criteria:
- Participants will be considered eligible for enrollment if they are between 18-65
years old, smoke at least ½ pack cigarettes per day, desire to quit smoking
(self-reported 75+ out of a possible 100), and have no contraindications for
varenicline medication therapy or fMRI scanning (such as body weight over 250 lbs,
intravascular metal devices including stents, or claustrophobia).
Exclusion Criteria:
- Participants will not be considered eligible for enrollment if they are not between
18-65 years old, smoke less than ½ pack cigarettes per day, do not desire to quit
smoking (self-reported -75 out of a possible 100), or have contraindications for
varenicline medication therapy or fMRI scanning (such as body weight over 250 lbs,
intravascular metal devices including stents, or claustrophobia).
We found this trial at
1
site
University of Pittsburgh The University of Pittsburgh is a state-related research university, founded as the...
Click here to add this to my saved trials
